Fitness experts expect clients to leave their programmes as weight loss jabs become available on the NHS. Rami Mwamba spoke ...

Eli Lilly reported impressive data at the recent American Diabetes Association ('ADA') conference. Its robust pipeline will ...

Adults with obesity were more likely to achieve a 10% or greater weight loss at 1 year if they continued using their ...

Reduced monthly costs for uninsured patients still amount to around $500. That can put the drugs out of reach for many.

Business Insider spoke to Eli Lilly's new president of cardiometabolic health, who shared the company's aggressive incretin ...

Sir Keir Starmer has set out his 10-year-plan to reform the NHS in England, based on a shift from hospitals to neighbourhood ...

Unsurprisingly, political leaders have seized on the promise of these drugs, hoping they might offer a ‘silver bullet’ (or ...

The Bengaluru-based company is seeking approval of generic Ozempic by September from Canadian authorities, and also in some ...

You've heard about the likes of Ozempic, Wegovy and Mounjaro, jabs which a growing number of people are taking in an attempt ...

Both semaglutide and tirzepatide for type 2 diabetes and weight loss are GLP-1 agonists, meaning they mimic the hormone.

As the NHS rolls out Mounjaro being prescribed by GPs on top of 1.5 million people in the UK using weight-loss medication in a single month, it's reported up to 20% of users don’t see the ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access information on a device and to provide personalised ads and content, ad and ...